| __timestamp | AbbVie Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 3297000000 | 31354781 |
| Thursday, January 1, 2015 | 4285000000 | 43445817 |
| Friday, January 1, 2016 | 4366000000 | 66489820 |
| Sunday, January 1, 2017 | 4982000000 | 96886134 |
| Monday, January 1, 2018 | 10329000000 | 153793000 |
| Tuesday, January 1, 2019 | 6407000000 | 148369000 |
| Wednesday, January 1, 2020 | 6557000000 | 151934000 |
| Friday, January 1, 2021 | 7084000000 | 198532000 |
| Saturday, January 1, 2022 | 6510000000 | 112128000 |
| Sunday, January 1, 2023 | 8453000000 | 76192000 |
| Monday, January 1, 2024 | 12791000000 |
Unleashing insights
In the ever-evolving landscape of biopharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, AbbVie Inc. and TG Therapeutics, Inc. have demonstrated contrasting strategies in their R&D investments. AbbVie, a global leader, has consistently increased its R&D spending, peaking in 2018 with a 213% rise from 2014. This commitment underscores its dedication to pioneering treatments and maintaining a competitive edge. Conversely, TG Therapeutics, a smaller player, has shown a more modest growth trajectory, with a 152% increase in R&D expenses over the same period. This reflects its focused approach to niche therapeutic areas. The data from 2014 to 2023 highlights the dynamic nature of R&D investments, emphasizing the critical role they play in driving medical breakthroughs and shaping the future of healthcare.
Comparing Innovation Spending: Novo Nordisk A/S and AbbVie Inc.
AbbVie Inc. or Gilead Sciences, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: AbbVie Inc. vs Insmed Incorporated
Who Prioritizes Innovation? R&D Spending Compared for AbbVie Inc. and Incyte Corporation
Research and Development Expenses Breakdown: AbbVie Inc. vs Exelixis, Inc.
AbbVie Inc. vs Amicus Therapeutics, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: AbbVie Inc. and Veracyte, Inc.
AbbVie Inc. vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Ascendis Pharma A/S and TG Therapeutics, Inc.
TG Therapeutics, Inc. or Ultragenyx Pharmaceutical Inc.: Who Invests More in Innovation?
TG Therapeutics, Inc. or Amneal Pharmaceuticals, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for TG Therapeutics, Inc. and Viking Therapeutics, Inc.